LGBT Cancer Project

Peritoneal Cancer Clinical Trials

A listing of Peritoneal Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Tucson Arizona

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Sutter West Bay
San Francisco California

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Long Beach California

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Los Angeles California 90048

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Monterey California 93940

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Francisco California 94115

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Stanford California 94305

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Colorado

Denver Colorado 80218

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

District of Columbia

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Florida

SCRI Florida Cancer Specialists
West Palm Beach Florida

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Miami Florida 33136

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Orlando Florida 32804

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Orlando Florida 32804

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Georgia

Northside Hospital
Atlanta Georgia

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Augusta Georgia 30912

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Illinois

University of Chicago
Chicago Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Northwestern University
Evanston Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Chicago Illinois

A clinical research study of COTI2

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of entinostat, avelumab and Placebo to evaluate Epithelial Ovarian Cancer, Peritoneal Cancer or Fallopian Tube Cancer

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Indiana

St. Vincent Hospital
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

IU Melvine and Bren Cancer Center
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Franciscan St. Francis Health
Indianapolis Indiana

A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Louisiana

Women’s Cancer Center
Covington Louisiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Women's Cancer Care
Covington Louisiana

A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Covington Louisiana 70433

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Maine

Scarborough Maine 04074

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Massachusetts

Lahey Clinic
Burlington Massachusetts

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Boston Massachusetts 02115

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston Massachusetts 02114

A clinical trial to evaluate treatments using Bevacizumab and Nivolumab for patients with Peritoneal Cancer, Ovarian Cancer or Fallopian Tube Cancer

Boston Massachusetts 02115

A clinical trial to evaluate treatments using Bevacizumab and Nivolumab for patients with Peritoneal Cancer, Ovarian Cancer or Fallopian Tube Cancer

Boston Massachusetts 02111

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Burlington Massachusetts 01805

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Michigan

Detroit Michigan

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Detroit Michigan 48201

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Minnesota

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

New Jersey

Morristown New Jersey 07960

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

New York

Biomedical Research Alliance of New York
Lake Success New York 11042

Advanced Relapsed Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer

North Shore Long Island Jewish
New Hyde Park New York

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Lake Success New York 11042

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lake Success New York 11042

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)